Will Stone

Well, for the most part, there have been a few cases in the U.S. where the source of infection was not identified. There was actually a child in San Francisco recently. There was a person in Missouri last year. That case in Canada, they also didn't know the exact source. Right. Yeah. This is concerning. We like to know how someone got infected.

Well, for the most part, there have been a few cases in the U.S. where the source of infection was not identified. There was actually a child in San Francisco recently. There was a person in Missouri last year. That case in Canada, they also didn't know the exact source. Right. Yeah. This is concerning. We like to know how someone got infected.

But at this point, it doesn't look like any of the other close contacts of these people were infected and that it was spreading between people. So the risk calculation could change quickly if we do see evidence of human to human spread. We're not there yet, though.

But at this point, it doesn't look like any of the other close contacts of these people were infected and that it was spreading between people. So the risk calculation could change quickly if we do see evidence of human to human spread. We're not there yet, though.

But at this point, it doesn't look like any of the other close contacts of these people were infected and that it was spreading between people. So the risk calculation could change quickly if we do see evidence of human to human spread. We're not there yet, though.

I would say the biggest action is around vaccines. No one in the US is being vaccinated for bird flu yet, but the US does have three H5N1 vaccines that were licensed and approved years ago because of concerns about future bird flu pandemics. Those shots were developed to target older strains of the virus.

I would say the biggest action is around vaccines. No one in the US is being vaccinated for bird flu yet, but the US does have three H5N1 vaccines that were licensed and approved years ago because of concerns about future bird flu pandemics. Those shots were developed to target older strains of the virus.

I would say the biggest action is around vaccines. No one in the US is being vaccinated for bird flu yet, but the US does have three H5N1 vaccines that were licensed and approved years ago because of concerns about future bird flu pandemics. Those shots were developed to target older strains of the virus.

There is some lab research that indicates they could still be protective against this newer version. But the federal government has actually been working to update those vaccines to target the strain that's circulating now better. This is kind of what we do with flu vaccine. You know, we update the strain. Every year to try to get a good match.

There is some lab research that indicates they could still be protective against this newer version. But the federal government has actually been working to update those vaccines to target the strain that's circulating now better. This is kind of what we do with flu vaccine. You know, we update the strain. Every year to try to get a good match.

There is some lab research that indicates they could still be protective against this newer version. But the federal government has actually been working to update those vaccines to target the strain that's circulating now better. This is kind of what we do with flu vaccine. You know, we update the strain. Every year to try to get a good match.

So the federal government has put in orders with vaccine makers for these updated shots. It's expected there'll be about 10 million of them stockpiled by early spring. These are two dose shots. So clearly, Gina, this is not nearly enough.

So the federal government has put in orders with vaccine makers for these updated shots. It's expected there'll be about 10 million of them stockpiled by early spring. These are two dose shots. So clearly, Gina, this is not nearly enough.

So the federal government has put in orders with vaccine makers for these updated shots. It's expected there'll be about 10 million of them stockpiled by early spring. These are two dose shots. So clearly, Gina, this is not nearly enough.

Yeah. Only compounding the issue here is that these vaccines rely on older technology. And so they can't just be churned out, you know, in a rapid timeframe.

Yeah. Only compounding the issue here is that these vaccines rely on older technology. And so they can't just be churned out, you know, in a rapid timeframe.

Yeah. Only compounding the issue here is that these vaccines rely on older technology. And so they can't just be churned out, you know, in a rapid timeframe.

And making things even more difficult is that the federal government doesn't want to preemptively make hundreds of millions of these shots because if bird flu does evolve significantly and can spread among humans, we expect it's going to look different and they may need to update the shot again. So it's a

And making things even more difficult is that the federal government doesn't want to preemptively make hundreds of millions of these shots because if bird flu does evolve significantly and can spread among humans, we expect it's going to look different and they may need to update the shot again. So it's a

And making things even more difficult is that the federal government doesn't want to preemptively make hundreds of millions of these shots because if bird flu does evolve significantly and can spread among humans, we expect it's going to look different and they may need to update the shot again. So it's a